I just read an article after Medtronic's earnings call - Why Medtronic plans to spin out its diabetes business. Quick Summary - Medtronic decided to spin out its diabetes business to focus on higher-margin segments like pulsed field ablation and renal denervation, as the diabetes unit operates differently, has lower margins, and benefits less from shared manufacturing and technology platforms.
Spine is the dog not barking.
What jumped out at me in this article is that Spine was not even mentioned. Medtronic's Spine business is a capital intensive and is losing market share to GloVasiv...